Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Cancer. 2017 Nov 10;124(4):816–825. doi: 10.1002/cncr.31114

Table 5.

Incidence of non-malignant late effects occurring ≥2 years after autoHCT

Organ Impairment Incidence, N (%)
Hypothyroidism 50 (3)
Diabetes 23 (1)
Gonadal dysfunction 16 (<1)
Cataracts 16 (<1)
Congestive heart failure 14 (<1)
Interstitial pneumonitis / idiopathic pneumonia syndrome 12 (<1)
Myocardial infarction 11 (<1)
Stroke/seizures 10 (<1)
Non-infectious liver toxicity 8 (<1)
Renal failure (severe) warranting dialysis 7 (<1)
Avascular necrosis 6 (<1)
Hemorrhagic cystitis 4 (<1)
Thrombotic thrombocytopenic purpura / hemolytic uremic syndrome 4 (<1)
Bronchiolitis obliterans 2 (<1)
Pulmonary hemorrhage 2 (<1)
Pancreatitis 1 (<1)